| ACLY | ATP citrate lyase |
| ACP | Acidic phosphatase |
| ADR | Adriamycin |
| AICAR | (5-Aminoimidazole-4-carboxamide-1-b-4-ribofuranoside |
| Akt | Protein kinase B |
| AMPK | Adenosine monophosphate-activated protein kinase |
| AMPKa | AMP-activated protein kinase |
| Ar-turmerone | Aromatic turmerone |
| ATM | Ataxia telangiectasia mutated |
| ATO | Arsenic trioxide |
| Bax | Bcl 2-associated X protein |
| Bcl | B cell lymphoma 2 |
| BCRP | Breast cancer resistance protein |
| Bid | BH3-interacting domain death agonist |
| BIP | Binding immunoglobulin protein |
| Cdc | Cell division cycle |
| CDKI | Cyclin-dependent kinases inhibitors |
| cFLIP | Cellular FLICE-like inhibitory protein |
| CHK2 | Checkpoint kinase 2 |
| cMet | Tyrosine-protein kinase Met |
| CNTM | Complete natural turmeric matrix |
| COX-2 | Cyclooxygenase -2 |
| CREB | Camp-response element |
| CTR | Calcitonin receptor |
| DC | Dendritic cells |
| DNA | Deoxyribonucleic acid |
| DNMT1 | DNA (cytosine-5)-methyltransferase 1 |
| DOXR | Doxorubicin |
| DR4 | Death receptor 4 |
| ED50 | Effective dose—50% |
| EGFR | Epithelial growth factor |
| ELISA | Enzyme-linked immunosorbent assay |
| EMT | Epithelial mesenchymal transition |
| ER | Endoplasmic reticulum |
| ERK | Extracellular regulated kinase |
| ER | α-Estrogen response |
| ETME | N-(β-Elemene-13-yl) tryptophan methyl ester |
| FACS | Fluorescence activated cell sorting |
| FAS | First apoptosis signal |
| FITC | Fluorescein isothiocyanate |
| FN | Furanodiene |
| GBM | Glioblastoma multiform |
| GFAP | Glial fibrillary acidic protein |
| GSCs | Glioblastoma stem cells |
| GSK | 3-Glycogen synthase kinase |
| HCC | Hepatocellular carcinoma |
| HER | Human epithelial growth receptor |
| HIF-1 | Hypoxia-inducible factors |
| HSC | Hepatic stellate cells |
| HUVEC | Human umbilical vein endothelial cells |
| IAPs | Inhibitor of apoptosis protein |
| IARC | The international agency for research on cancer |
| IC50 | Half-maximal inhibitory concentration |
| IGF-1R | Insulin-like factor-1 receptor |
| IL2 | Interleukin 2 |
| JAK | JANUS-activated kinases |
| JNK | c Jun N terminal kinase |
| LDH | Lactate dehydrogenase |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen activated protein kinase |
| MDR | Multi-resistance protein gene |
| MKK | Mitogen-activated protein kinase kinase |
| MMP-9 | Matrix metalloproteinase -9 |
| MMP | Mitochondrial membrane potential |
| mRNA | Messenger ribonucleic acid |
| Myc | Myelocytomatosis |
| NAC | N-acetyl cysteine |
| NF-κB | Nuclear factor kappa light chain enhancer of activated B cells |
| NFATc-1 | Nuclear factor of activated T-cells, cytoplasmic 1 |
| NLC | Nanostructured lipid carriers |
| NSCLC | Non-small cell lung cancer cell |
| N-WASP | Neural Wiskott-Aldrich syndrome protein |
| PARP | Poly (ADP-ribose) polymerase; PARP |
| PCNA | Protein cell nuclear antigen |
| P-gp | Permeability glycoprotein |
| Phosphor-cdc2 | Phosphorylated cell division cycle 2 |
| PKC | Protein kinase C |
| PLGA | Poly (lactic-co-glycolic acid) |
| PUMA | p 53 upregulated modulator of apoptosis |
| RANKL | Receptor activator of nuclear factor kappa-Β ligand |
| ROS | Reactive oxygen species |
| RT-PCR | Reverse transcription polymerase chain reaction |
| SHH | Sonic hedgehog |
| SLN | Solid lipid nanoparticles |
| STAT | Signal transducer and activator of transcription |
| TAM | Tamoxifen |
| TMZ | Temozolomide |
| TNF | Tumor necrosis factor |
| TPA | 12-O-tetradecanoylphorbol-13-acetate |
| TRAP | Tartrate-resistant acid phosphatase |
| VCAM | Vascular cell adhesion molecules |
| VEGF | Vascular endothelial growth factor |
| WST-1 | Water soluble tetrazolium salts-1 |
| z-DEVD-fmk | Z-D (OMe)E (OMe)VD(OMe) fluoromethylketone |